We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
-3.28%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$15.4B
AUM Growth
+$3.25B
(+27%)
Cap. Flow
+$3.84B
Cap. Flow
% of AUM
24.9%
Top 10 Holdings %
Top 10 Hldgs %
24.83%
Holding
2,819
New
321
Increased
2,347
Reduced
46
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$246M |
| 2 |
Microsoft
MSFT
|
+$216M |
| 3 |
Amazon
AMZN
|
+$130M |
| 4 |
Tesla
TSLA
|
+$79.6M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$73.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$49.3M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$11.7M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$11.6M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$5.56M |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$5.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Healthcare | 12.21% |
| 3 | Financials | 12.1% |
| 4 | Consumer Discretionary | 11.41% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Full House Resorts
FLL
$85M
| $177K | ﹤0.01% |
18,465
+6,625
| +56% | +$61.5K |
|
|
KRON
2427
DELISTED
Kronos Bio
KRON
| $177K | ﹤0.01% |
24,534
+9,055
| +58% | +$77.2K |
|
|
BKI
2428
DELISTED
Black Knight, Inc. Common Stock
BKI
| $176K | ﹤0.01% |
+3,038
| New | +$200K |
|
|
FMTX
2429
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $176K | ﹤0.01% |
18,930
+6,986
| +58% | +$74.4K |
|
2430
Daily Journal
DJCO
$779M
| $176K | ﹤0.01% |
564
+222
| +65% | +$72.2K |
|
2431
Aviat Networks
AVNW
$284M
| $176K | ﹤0.01% |
5,718
+2,110
| +58% | +$61.6K |
|
2432
National Presto Industries
NPK
$985M
| $176K | ﹤0.01% |
2,284
+876
| +62% | +$71.1K |
|
|
ESTE
2433
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $176K | ﹤0.01% |
13,900
+4,832
| +53% | +$63K |
|
|
KNTE
2434
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $175K | ﹤0.01% |
15,585
+5,658
| +57% | +$62.3K |
|
2435
Procept Biorobotics
PRCT
$1.25B
| $175K | ﹤0.01% |
+5,008
| New | +$121K |
|
|
TEAD
2436
Teads Holding Co
TEAD
$64.3M
| $175K | ﹤0.01% |
+16,314
| New | +$205K |
|
|
BNFT
2437
DELISTED
Benefitfocus, Inc.
BNFT
| $175K | ﹤0.01% |
13,846
+4,937
| +55% | +$52.7K |
|
2438
Brookfield Renewable
BEPC
$6.6B
| $175K | ﹤0.01% |
+3,986
| New | +$147K |
|
2439
NVE Corp
NVEC
$571M
| $174K | ﹤0.01% |
3,201
+1,131
| +55% | +$66.8K |
|
2440
iRadimed
IRMD
$1.11B
| $174K | ﹤0.01% |
3,886
+1,395
| +56% | +$64.5K |
|
2441
Aramark
ARMK
$16.2B
| $174K | ﹤0.01% |
+6,415
| New | +$167K |
|
2442
Omeros
OMER
$1.22B
| $174K | ﹤0.01% |
28,967
+16,862
| +139% | +$105K |
|
2443
Lifecore Biomedical
LFCR
$179M
| $174K | ﹤0.01% |
15,010
+12,372
| +469% | +$138K |
|
|
SCU
2444
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $174K | ﹤0.01% |
12,461
+4,296
| +53% | +$69.6K |
|
|
MNDT
2445
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $173K | ﹤0.01% |
+7,755
| New | +$143K |
|
2446
Kiniksa Pharmaceuticals
KNSA
$6.1B
| $172K | ﹤0.01% |
17,349
+6,262
| +56% | +$66.3K |
|
2447
RBB Bancorp
RBB
$465M
| $172K | ﹤0.01% |
7,339
+2,663
| +57% | +$68.3K |
|
2448
Blue Bird Corp
BLBD
$2.07B
| $172K | ﹤0.01% |
9,160
+3,398
| +59% | +$61.9K |
|
2449
Shift4
FOUR
$3.61B
| $172K | ﹤0.01% |
+2,778
| New | +$147K |
|
|
AFCG
2450
AFC Gamma
AFCG
$70.5M
| $172K | ﹤0.01% |
13,137
+4,684
| +55% | +$63.3K |
|
Similar funds
SPIA
BG
PCM
CS
HHII
EIM
P
MetLife Investment Management's Q1 2022 Portfolio in Review
As of Q1 2022, MetLife Investment Management held 2,819 positions worth $15.4B, up 27% from $12.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
MetLife Investment Management deployed $3.84B of net new capital in Q1 2022, opening 321 new positions and adding to 2,347 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 519,200 shares worth $36M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $49.3M trimmed.
- MetLife Investment Management's largest Q1 2022 buy was iShares Russell 1000 Growth ETF: 519,200 shares worth $36M.
- MetLife Investment Management added most to Apple in Q1 2022, an estimated $246M increase.
- MetLife Investment Management's biggest Q1 2022 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $49.3M.
- MetLife Investment Management fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $11.7M.
- MetLife Investment Management's ten largest holdings make up 25% of its $15.4B portfolio in Q1 2022.
- MetLife Investment Management opened 321 new positions and closed 92 in Q1 2022.
- MetLife Investment Management's portfolio value rose 27% quarter-over-quarter to $15.4B.
Based on MetLife Investment Management's 13F filing for Q1 2022, filed 12 May 2022.